At 31, Amber Sims discovered that a quiet bodily instinct — and a new self-administered screening test — may have saved her life, when what seemed like routine blood work in mid-2025 led to a diagnosis of stage 3C1 cervical cancer. What followed was eleven weeks of gruelling treatment across the holiday season, sustained not only by medicine but by the particular human gifts of presence, listening, and the refusal to reduce a person to their illness. Her story sits at the intersection of medical innovation and ancient wisdom: that technology opens the door, but it is care — from family, from f
Self-administered cervical cancer test catches stage 3C1 diagnosis in 31-year-old
31-year-old woman diagnosed with stage 3C1 cervical cancer requiring 11 weeks of chemotherapy, 25 radiation rounds, and 4 brachytherapy sessions; experienced significant physical and psychological burden during treatment.